Journal profile · Medicine, General & Internal
DM DISEASE-A-MONTH
ISSN 0011-5029 · eISSN 1557-8194 · Mosby Inc. · UNITED STATES · Monthly · Founded 1954
DM DISEASE-A-MONTH: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.66; hybrid open access; APC about USD 3,580; review over 12 weeks (community reports); community-reported acceptance: easy; 84 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
DM DISEASE-A-MONTH is published by Mosby Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diverse Scientific and Economic Studies, Human auditory perception and evaluation and Educational Robotics and Engineering, together about 58.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Designed for primary care physicians, each issue of Disease-a-Month presents an in-depth review of a single topic. In this way, the publication can cover all aspects of the topic - pathophysiology, clinical features of the disease or condition, diagnostic techniques, therapeutic approaches, and prognosis.
From the journal's Aims & Scope
Research area (LetPub): Medicine, General & Internal
Editor-in-chief Jerrold LeikinPublisher website
Editorial board by country: none in mainland China; most named United States 9 (9 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance27.4%
- Human auditory perception and evaluationEngineering15.7%
- Educational Robotics and EngineeringComputer Science15.2%
- Ferroelectric and Negative Capacitance DevicesEngineering9.7%
- Big Data and Digital EconomyComputer Science9.2%
- Legal Cases and CommentaryMedicine3.3%
- Venous Thromboembolism Diagnosis and ManagementMedicine2.2%
- Occupational Therapy Practice and ResearchHealth Professions1.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, General & Internal | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, General & Internal | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, General & Internal | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.66LetPub ·
- Impact factor (publisher)
- 5.7Publisher website ·
- CiteScore 2026-06
- 5.5LetPub ·
- CiteScore (publisher)
- 5.5Publisher website ·
- SJR 2026-06
- 0.76LetPub ·
- SNIP 2026-06
- 1.06LetPub ·
- h-index
- 32LetPub ·
- h-index
- 74OpenAlex ·
- i10-index
- 624OpenAlex ·
- 2-year mean citedness
- 1.33OpenAlex ·
- Self-citation rate
- 1.8%LetPub ·
- Share of gold OA articles
- 5.41%LetPub ·
Volume
- Articles per year
- 19LetPub ·
Articles by year OpenAlex count · 3,216 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 79 | 11 | 5 |
| 2025 | 84 | 11 | 203 |
| 2024 | 86 | 21 | 123 |
| 2023 | 73 | 2 | 356 |
| 2022 | 138 | 7 | 530 |
| 2021 | 90 | 1 | 708 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance to publication
- 16 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,580 / EUR 3,350 / GBP 2,870 / JPY 444,030 | — | — | |
| Publisher website | USD 3,780 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- AMA
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
No authorship changes after acceptance Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Mosby Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1954
- ISSN
- 0011-5029
- Electronic ISSN
- 1557-8194
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about DM DISEASE-A-MONTH
What CAS zone is DM DISEASE-A-MONTH in?
In the 2025 upgraded edition of the CAS Journal Ranking, DM DISEASE-A-MONTH is in Zone 3 of Medicine, and in Zone 3 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of DM DISEASE-A-MONTH?
The latest impact factor listed by LetPub is 5.66; CiteScore 5.5, h-index 74.
How long does peer review take at DM DISEASE-A-MONTH?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of DM DISEASE-A-MONTH?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: AMA. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of DM DISEASE-A-MONTH based?
Of the 9 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (9). Counted from the institutions listed on the board page; for reference only.
Which databases index DM DISEASE-A-MONTH?
According to LetPub and DOAJ records, DM DISEASE-A-MONTH is indexed in SCIE and Scopus.
Is DM DISEASE-A-MONTH open access, and what is the APC?
DM DISEASE-A-MONTH is a hybrid journal. For open-access publication: APC about USD 3,580.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .